Intraocular penetration of intravenous micafungin in inflamed human eyes

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 8, 2013, Pages 4027-4030

  Mochizuki, Kiyofumi ^a   Sawada, Akira ^a   Suemori, Shinsuke ^a   Kawakami, Hideaki ^b   Niwa, Yoshiaki ^c   Kondo, Yuji ^d   Ohkusu, Kiyofumi ^a   Yamada, Noriaki ^e   Ogura, Shinji ^e   Yaguchi, Takashi ^f   Nishimura, Kazuko ^g   Kishinoi, Satoshi ^h  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Gifu Municipal Hospital   (Japan)

^c GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^d Chuno Kosei Hospital   (Japan)

^e GIFU UNIVERSITY   (Japan)

^f CHIBA UNIVERSITY   (Japan)

^g DOKKYO MEDICAL UNIVERSITY   (Japan)

^h MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MICAFUNGIN; MICONAZOLE; VORICONAZOLE;

AGED; AQUEOUS HUMOR; ARTICLE; BLOOD SAMPLING; CHOROID; CLINICAL ARTICLE; CORNEA; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG PENETRATION; ENUCLEATION; EYE; FEMALE; FUNGAL ENDOPHTHALMITIS; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; VITRECTOMY; VITREOUS BODY;

AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; AQUEOUS HUMOR; ASPERGILLUS; CANDIDA; CORNEA; ECHINOCANDINS; ENDOPHTHALMITIS; FEMALE; HUMANS; INJECTIONS, INTRAOCULAR; LIPOPEPTIDES; MALE; VITRECTOMY; VITREOUS BODY;

EID: 84880302115     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02300-12     Document Type: Article

References (20)

1. Shah CP, McKey J, Spirn MJ, Maguire J. 2008. Ocular candidiasis: a review. Br. J. Ophthalmol. 92:466-468.
2. Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR. 2008. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br. J. Ophthalmol. 92:871-878.
3. Kuse ER, Chetchotisakd P, da Cunha CA, Ruhnke M, Barrios C, Raghunadharao D, Sekhon JS, Freire A, Ramasubramanian V, Demeyer I, Nucci M, Leelarasamee A, Jacobs F, Decruyenaere J, Pittet D, Ullmann AJ, Ostrosky-Zeichner L, Lortholary O, Koblinger S, Diekmann-Berndt H, Cornely OA, Micafungin Invasive Candidiasis Working Group. 2007. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet 369:1519-1527.
4. Venditti M. 2009. Clinical aspects of invasive candidiasis: endocarditis and other localized infections. Drugs 69(Suppl 1):39-43.
5. Suzuki T, Uno T, Chen G, Ohashi Y. 2008. Ocular distribution of intravenously administered micafungin in rabbits. J. Infect. Chemother. 14:204-207.
6. Yamato Y, Kaneko H, Tanimoto K, Katashima M, Ishibashi K, Kawamura A, Terakawa M, Kagayama A. 2002. Simultaneous determination of antifungal drug, micafungin, and its two active metabolites in human plasma using high-performance liquid chromatography with fluorescence detection. Jpn. J. Chemother. 50(Suppl 1):68-73.
7. Niwa T, Yokota Y, Tokunaga A, Yamato Y, Kagayama A, Fujiwara T, Hatakeyama J, Anezaki M, Ohtsuka Y, Takagi A. 2004. Tissue distribution after intravenous dosing of micafungin, an antifungal drug, to rats. Biol. Pharm. Bull. 27:1154-1156.
8. Ferrer C, Colom F, Frasés S, Mulet E, Abad JL, Alió JL. 2001. Detection and identification of fungal pathogens by PCR and by ITS2 and 5.8S ribosomal DNA typing in ocular infections. J. Clin. Microbiol. 39:2873-2879.
9. Kredics L, Varga J, Kocsubé S, Rajaraman R, Raghavan A, Dóczi I, Bhaskar M, Németh TM, Antal Z, Venkatapathy N, Vágvölgyi C, Samson RA, Chockaiya M, Palanisamy M. 2009. Infectious keratitis caused by Aspergillus tubingensis. Cornea 28:951-954.
10. CLSI. 2008. Method for antifungal disk diffusion susceptibility testing of yeasts; approved standard, 3rd ed. Document M27-A3. Clinical and Laboratory Standards Institute, Wayne, P. A.
11. CLSI. 2008. Method for antifungal disk diffusion susceptibility testing of filamentous fungi; approved standard, 3rd ed. Document M38-A2. Clinical and Laboratory Standards Institute, Wayne, P. A.
12. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Jr, Calandra TF, Edwards JE, Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48:503-535.
13. Pfaller MA, Castanheira M, Messer SA, Moet GJ, Jones RN. 2011. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009). Diagn. Microbiol. Infect. Dis. 69:45-50.
14. Moyer AL, Ramadan RT, Novosad BD, Astley R, Callegan MC. 2009. Bacillus cereus-induced permeability of the blood-ocular barrier during experimental endophthalmitis. Invest. Ophthalmol. Vis. Sci. 50:3783-3793.
15. Groll AH, Mickiene D, Petraitis V, Petraitiene R, Ibrahim KH, Piscitelli SC, Bekersky I, Walsh TJ. 2001. Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits. Antimicrob. Agents Chemother. 45:3322-3327.
16. Spriet I, Delaere L, Lagrou K, Peetermans WE, Maertens J, Willems L. 2009. Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis. J. Antimicrob. Chemother. 64:877-878.
17. Gauthier GM, Nork TM, Prince R, Andes D. 2005. Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis. Clin. Infect. Dis. 41:e27-28.
18. Mochizuki K, Suemori S, Udo K, Komori S, Ohkusu K, Yamada N, Ogura S. 2011. Intraocular penetration of micafungin in patient with Candida albicans endophthalmitis. J. Ocul. Pharmacol. Ther. 27:531-533.
19. Azuma J, Nakahara K, Kagayama A, Okuma T, Kawamura A, Mukai T. 2002. Pharmacokinetic study of micafungin. Jpn. J. Chemother. 50(Suppl 1):155-184.
20. Goldblum D, Fausch K, Frueh BE, Theurillat R, Thormann W, Zimmerli S. 2007. Ocular penetration of caspofungin in a rabbit uveitis model. Graefes Arch. Clin. Exp. Ophthalmol. 245:825-833.